Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia.
Reasonable growth potential with imperfect balance sheet.
Share Price & News
How has Ryman Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: RYM has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: RYM exceeded the NZ Healthcare industry which returned 32.7% over the past year.
Return vs Market: RYM exceeded the NZ Market which returned 21.9% over the past year.
Price Volatility Vs. Market
How volatile is Ryman Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StRyman Healthcare Limited (NZSE:RYM) Delivered A Better ROE Than Its Industry
1 month ago | Simply Wall StWe're Not Counting On Ryman Healthcare (NZSE:RYM) To Sustain Its Statutory Profitability
1 month ago | Simply Wall StRyman Healthcare Limited (NZSE:RYM): Does The Earnings Decline Make It An Underperformer?
Is Ryman Healthcare undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: RYM (NZ$17.04) is trading above our estimate of fair value (NZ$6.54)
Significantly Below Fair Value: RYM is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: RYM is poor value based on its PE Ratio (24.7x) compared to the Healthcare industry average (24.4x).
PE vs Market: RYM is poor value based on its PE Ratio (24.7x) compared to the NZ market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: RYM is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: RYM is overvalued based on its PB Ratio (3.7x) compared to the NZ Healthcare industry average (1.2x).
How is Ryman Healthcare forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RYM's forecast earnings growth (20.3% per year) is above the savings rate (1.3%).
Earnings vs Market: RYM's earnings (20.3% per year) are forecast to grow faster than the NZ market (6.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: RYM's revenue (11.3% per year) is forecast to grow faster than the NZ market (5.1% per year).
High Growth Revenue: RYM's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RYM's Return on Equity is forecast to be low in 3 years time (12.1%).
How has Ryman Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RYM has a large one-off gain of NZ$317.5M impacting its September 30 2019 financial results.
Growing Profit Margin: RYM's current net profit margins (85.7%) are lower than last year (97.5%).
Past Earnings Growth Analysis
Earnings Trend: RYM's earnings have grown by 7.8% per year over the past 5 years.
Accelerating Growth: RYM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: RYM had negative earnings growth (-2.9%) over the past year, making it difficult to compare to the Healthcare industry average (-2.9%).
Return on Equity
High ROE: RYM's Return on Equity (15%) is considered low.
Return on Assets
Return on Capital Employed
How is Ryman Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: RYM's short term assets (NZ$343.8M) exceed its short term liabilities (NZ$184.4M).
Long Term Liabilities: RYM's short term assets (NZ$343.8M) do not cover its long term liabilities (NZ$4.8B).
Debt to Equity History and Analysis
Debt Level: RYM's debt to equity ratio (66.5%) is considered high.
Reducing Debt: RYM's debt to equity ratio has increased from 39.1% to 66.5% over the past 5 years.
Debt Coverage: RYM's debt is well covered by operating cash flow (28.8%).
Interest Coverage: RYM's interest payments on its debt are not well covered by EBIT (3x coverage).
Inventory Level: RYM has a high level of physical assets or inventory.
Debt Coverage by Assets: RYM's debt is not covered by short term assets (assets are 0.2x debt).
What is Ryman Healthcare's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: RYM's dividend (1.33%) isn’t notable compared to the bottom 25% of dividend payers in the NZ market (2.87%).
High Dividend: RYM's dividend (1.33%) is low compared to the top 25% of dividend payers in the NZ market (5.53%).
Stability and Growth of Payments
Stable Dividend: RYM is not paying a notable dividend for the NZ market, therefore no need to check if payments are stable.
Growing Dividend: RYM is not paying a notable dividend for the NZ market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: RYM is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of RYM's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gordon MacLeod 0
Mr. Gordon MacLeod has been the Chief Executive Officer since July 1, 2017 of Ryman Healthcare Limited since October 26, 2006 and serves as its Secretary and served as its Deputy Chief Executive and Chief ...
CEO Compensation Analysis
Compensation vs Market: Gordon's total compensation ($USD785.30K) is below average for companies of similar size in the NZ market ($USD1.18M).
Compensation vs Earnings: Gordon's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|CEO & Secretary||2.6yrs||NZ$1.23m||0.13% NZ$11.3m|
|Chief Financial Officer||2.7yrs||no data||0.026% NZ$2.2m|
|Chief Operations Officer||0.08yrs||no data||no data|
|Chief People & Technology Officer||0yrs||no data||0.022% NZ$1.8m|
|Chief Sales & Marketing Officer||3.2yrs||no data||0.055% NZ$4.7m|
|Chief Construction Officer||0yrs||no data||0.068% NZ$5.8m|
|Chief Development Officer||0.08yrs||no data||0.014% NZ$1.2m|
|Head of Research & New Opportunities||0.08yrs||no data||no data|
Experienced Management: RYM's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
|Independent Chairman of the Board||21.1yrs||NZ$217.00k||0.070% NZ$5.9m|
|Advisor to the Board||2.8yrs||NZ$2.73m||no data|
|Independent Non-Executive Director||7.1yrs||NZ$136.01k||0.011% NZ$921.1k|
|Deputy Chairman||0yrs||NZ$125.50k||0.00030% NZ$25.4k|
|Independent Non-Executive Director||11.1yrs||NZ$108.00k||0.016% NZ$1.3m|
|Independent Non-Executive Director||5.4yrs||NZ$136.01k||0.0025% NZ$215.4k|
|Independent Director||0.3yrs||no data||no data|
|Independent Director||1.3yrs||NZ$62.75k||0.0020% NZ$170.5k|
Experienced Board: RYM's board of directors are considered experienced (4.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: RYM insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ryman Healthcare Limited's company bio, employee growth, exchange listings and data sources
- Name: Ryman Healthcare Limited
- Ticker: RYM
- Exchange: NZSE
- Founded: 1984
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: NZ$8.481b
- Shares outstanding: 497.74m
- Website: https://www.rymanhealthcare.co.nz
Number of Employees
- Ryman Healthcare Limited
- Airport Business Park
- 92 Russley Road
- New Zealand
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|RYM||NZSE (New Zealand Stock Exchange)||Yes||Ordinary Shares||NZ||NZD||Jun 1999|
|RHCG.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jun 1999|
|RH7||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jun 1999|
|RYHT.Y||OTCPK (Pink Sheets LLC)||UNSPONSORED ADR||US||USD||Nov 2011|
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. Its villages offer a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which provides rest homes, hospitals, and dementia level care. The company’s villages also offer lounges and bar, indoor swimming pool and spa, gym, beauty salon, bowling green, library, Internet café, movie theatre, and other facilities. It owns and operates 36 retirement villages and serves 11,000 residents. The company was founded in 1984 and is based in Christchurch, New Zealand.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/19 10:35|
|End of Day Share Price||2020/02/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.